103 related articles for article (PubMed ID: 9082756)
1. Human tonsillar lymphocytes as targets for immunosuppressive and anticancer drugs.
Staub M; Sasvari-Szekely M; Spasokukotskaja T; Piroth Z; Kazimierczuk Z
Acta Otolaryngol Suppl; 1996; 523():124-7. PubMed ID: 9082756
[TBL] [Abstract][Full Text] [Related]
2. Similar changes were induced by Cladribine and by gemcitabine, in the deoxypyrimidine salvage, during short-term treatments.
Csapó Z; Keszler G; Sasvári-Székely M; Smid K; Noordhuis P; Peters GJ; Staub M
Adv Exp Med Biol; 1998; 431():525-9. PubMed ID: 9598122
[TBL] [Abstract][Full Text] [Related]
3. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
[TBL] [Abstract][Full Text] [Related]
4. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M
Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083
[TBL] [Abstract][Full Text] [Related]
6. Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF.
Csapó Z; Sasvári-Székely M; Spasokoukotskaja T; Staub M
Acta Biochim Pol; 2001; 48(1):251-6. PubMed ID: 11440177
[TBL] [Abstract][Full Text] [Related]
7. [Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation].
Staub M
Magy Onkol; 2004; 48(3):229-34. PubMed ID: 15520873
[TBL] [Abstract][Full Text] [Related]
8. Reversible permeabilization of lymphocytes destroys the incorporation of deoxythymidine but not of deoxycytidine.
Taljanidisz J; Sasvari-Szekely M; Spasokutotskaja T; Antoni F; Staub M
Biochim Biophys Acta; 1986 Mar; 885(3):266-71. PubMed ID: 3947681
[TBL] [Abstract][Full Text] [Related]
9. Activation of deoxycytidine kinase by various nucleoside analogues.
Spasokoukotskaja T; Sasvári-Székely M; Hullán L; Albertioni F; Eriksson S; Staub M
Adv Exp Med Biol; 1998; 431():641-5. PubMed ID: 9598144
[TBL] [Abstract][Full Text] [Related]
10. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells.
Smal C; Cardoen S; Bertrand L; Delacauw A; Ferrant A; Van den Berghe G; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2004 Jul; 68(1):95-103. PubMed ID: 15183121
[TBL] [Abstract][Full Text] [Related]
11. Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2'-deoxyadenosine (Cladribine) in human lymphocytes.
Sasvári-Székely M; Spasokoukotskaja T; Szóke M; Csapó Z; Turi A; Szántó I; Eriksson S; Staub M
Biochem Pharmacol; 1998 Nov; 56(9):1175-9. PubMed ID: 9802328
[TBL] [Abstract][Full Text] [Related]
12. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
[TBL] [Abstract][Full Text] [Related]
13. Pyrimidine salvage enzymes in human tonsil lymphocytes: II. Purification and properties of deoxycytidine kinase.
Szyfter K; Sasvári-Székely M; Spasokukotskaja T; Antoni F; Staub M
Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):173-82. PubMed ID: 3019066
[TBL] [Abstract][Full Text] [Related]
14. A novel effect of the new antileukemic drug, 2-chloro-2'-deoxyadenosine, in human lymphocytes.
Sasvári-Székely M; Piróth Z; Kazimierczuk Z; Staub M
Biochem Biophys Res Commun; 1994 Sep; 203(3):1378-84. PubMed ID: 7945284
[TBL] [Abstract][Full Text] [Related]
15. Activation of deoxycytidine kinase during inhibition of DNA synthesis in human lymphocytes.
Sasvári-Székely M; Csapó Z; Spasokoukotskaja T; Eriksson S; Staub M
Adv Exp Med Biol; 1998; 431():519-23. PubMed ID: 9598121
[TBL] [Abstract][Full Text] [Related]
16. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
Balzarini J; De Clercq E
Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
[TBL] [Abstract][Full Text] [Related]
17. Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity.
Spasokoukotskaja T; Sasvári-Székely M; Keszler G; Albertioni F; Eriksson S; Staub M
Eur J Cancer; 1999 Dec; 35(13):1862-7. PubMed ID: 10674004
[TBL] [Abstract][Full Text] [Related]
18. Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy.
Johnsamuel J; Eriksson S; Oliveira M; Tjarks W
Bioorg Med Chem; 2005 Jul; 13(13):4160-7. PubMed ID: 15876539
[TBL] [Abstract][Full Text] [Related]
19. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
Ross DD; Akman SA; Schrecker AW; Bachur NR
Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
[TBL] [Abstract][Full Text] [Related]
20. Deoxycytidine kinase can be also potentiated by the G-protein activator NaF in cells.
Staub M; Csapó Z; Spasokukotskaja T; Sasvári-Székely M
Adv Exp Med Biol; 1998; 431():425-8. PubMed ID: 9598103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
